Clinical Trial Update: Liposomal Amphotericin B and Flucytosine Antifungal Strategy for Talaromycosis (LAmB-FAST) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating liposomal amphotericin B in combination with flucytosine for talaromycosis. The study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Talaromycosis

Drugs mentioned

• AMBISOME (AMPHOTERICIN B)
• Flucytosine (flucytosine)

Snippet

Sponsor: Duke University | Conditions: Talaromycosis | Phase 3 | Status: NOT_YET_RECRUITING